A cost comparison of photodynamic therapy and metallic stents in the palliation of oesophageal cancer☆
To access this article, please choose from the options below
☆ This work was supported by Axcan Pharma Inc., UK.
PII: S1572-1000(06)00148-7
doi:10.1016/j.pdpdt.2006.10.005
© 2006 Elsevier B.V. All rights reserved.
